Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
Jianmin Zuo(Institut thématique Immunologie, inflammation, infectiologie et microbiologie), Paul Moss(University Hospitals Birmingham NHS Foundation Trust)
Cited by 420
Related Papers
CMV and Immunosenescence: from basics to clinics
|Immunity & Ageing|2012|182
New advances in CMV and immunosenescence
|Experimental Gerontology|2014|149
Cytomegalovirus viral load within blood increases markedly in healthy people over the age of 70 years
|Immunity & Ageing|2016|126
Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
|bioRxiv (Cold Spring Harbor Laboratory)|2020|80
Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
|Research Square|2020|13